NIH-funded research R01 grant

Finding the best ways to prevent heart disease in cancer survivors

Official title: Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors

Funded at Icahn School of Medicine at Mount Sinai · NIH-10995346 · Data updated 2026-11-12

This study is looking for the best ways to help cancer survivors—especially those who had breast, prostate, or lung cancer—stay heart-healthy by understanding how their cancer treatments and other health factors work together.

More Cardiovascular Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$697,894
NIH project number5R01CA271604-03
Project IDNIH-10995346 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have survived breast, prostate, or lung cancer and are at risk for cardiovascular disease.

Less likely to help

Patients who are currently undergoing active cancer treatment or have other unrelated severe health conditions may not benefit from this research.

What this research studies

This research aims to identify effective strategies for preventing cardiovascular disease (CVD) among survivors of breast, prostate, and lung cancer. It focuses on understanding how traditional CVD risk factors and cancer treatments interact to affect heart health. By analyzing data from over 6 million cancer survivors, the study will explore tailored prevention methods that consider both cancer-related risks and the unique health challenges faced by these patients. The goal is to improve overall health outcomes and quality of life for cancer survivors.

Why it matters

Potential benefit: If successful, this research could significantly reduce the risk of heart disease in cancer survivors, improving their long-term health and survival rates.

How similar studies have gone: Previous research has shown promising results in using tailored prevention strategies for cardiovascular disease in other high-risk populations, suggesting potential success for this approach in cancer survivors.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Wisnivesky, Juan P — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Wisnivesky, Juan P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.